COMETE, a network for the study and management of hypersecreting adrenal tumors;Le réseau national COMETE sur les tumeurs de la surrénale

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 1, 2008, Pages 73-85

  Plouin, Pierre François ^a   Gimenez Roqueplo, Anne Paule ^b   Bertagna, Xavier ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Adrenal gland neoplasms; Aldosterone; Catecholamines; Hydrocortisone; Hypertension; Prognosis; Recurrence

Indexed keywords

ADENOMA; ADRENAL TUMOR; ARTICLE; FRANCE; HUMAN; MEDICAL SOCIETY; METABOLISM; ORGANIZATION AND MANAGEMENT; PHEOCHROMOCYTOMA; RESEARCH;

ADENOMA; ADRENAL GLAND NEOPLASMS; FRANCE; HUMANS; PHEOCHROMOCYTOMA; RESEARCH; SOCIETIES, MEDICAL;

EID: 54049101228     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32869-9     Document Type: Article

References (14)

1. http://www.sante.gouv.fr/htm/actu/phrc/rch-cliniq.htm
2. [2] BAYSAL B.E., FERRELL R.E., WILLETT-BROZICK LE. et al-Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science, 2000, 287, 848-851. (Pubitemid 30084326)
3. NEUMANN H.P., BAUSCH B., MCWHINNEY S.R. et al. -Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med, 2002, 346, 1459-1466.
4. [4] AMAR L. BERTHERAT J., BAUDIN E. et al. -Genetic testing in pheochromocytoma and functional paraganglioma. J. Clin. Oncol., 2005, 34, 8812-8818. (Pubitemid 46211527)
5. [5] PLOUIN P.F., GIMENEZ-ROQUEPLO A.P. -The genetic basis of pheochromocytoma : who to screen and how ? Nat. Clin. Pract. Endocrinol. Metab., 2006, 2, 60-61. (Pubitemid 44446911)
6. [6] GIMENEZ-ROQUEPLO A.P., FAVIER J., RUSTIN P. et al. -The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet., 2001, 69, 1186-1197. (Pubitemid 33124200)
7. BRIÉRE J. J., FAVIER J., BÉNIT P. et al. -Mitochondrial succinate is instrumental for HIFlalpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. N Mol. Genet., 2005, 14, 3263-3269.
8. FAVIER J., PLOUIN P.F., CORVOL P., GASC J.M. -Angiogenesis and vascular architecture in pheochromocytomas : distinctive traits in malignant tumors. Am. J. Pathol, 2002,161, 12351246.
9. [9] GIMENEZ-ROQUEPLO A.P., FAVIER J., RUŠTIN P. et al. -Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res., 2003, 63, 5615-5621. (Pubitemid 37139886)
10. [10] BENN D., GIMENEZ-ROQUEPLO A.P., REILLY J. et al. -Clinical presentation and penetrance of phaeochromocytoma/paraganglioma syndrome. J. Clin. Endocrinol. Metab., 2006, 91, 827-836. (Pubitemid 43357746)
11. [11] BERTHERAT J., GROUSSIN L., BERTAGNAX.-Mechanisms of disease : adrenocortical tumors- molecular advances and clinical perspectives. Nat. Clin. Pract. Endocrinol. Metab., 2006, in press. (Pubitemid 44691299)
12. [12] HORVATH A., BOIKOS S., GIATZAKIS C. et al. -A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11 A4 (PDE 11 A4) in individuals with adrenocortical hyperplasia. Nat. Genet., 2006, 38, 794-800. (Pubitemid 43980600)
13. [13] ABIVEN G., COSTE J., GROUSSIN L. et al. -Clinical and biological features in the prognosis of adrenocortical cancer : poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J. Clin. Endocrinol. Metab., 2006, 91, 2650-2655. (Pubitemid 44024632)
14. [14] GICQUEL C., BERTAGNA X., GASTON V. et al. -Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res., 2001, 61, 6762-6767. (Pubitemid 32896498)